154 related articles for article (PubMed ID: 23039902)
1. The importance of spleen, spleen iron, and splenectomy for determining total body iron load, ferrikinetics, and iron toxicity in thalassemia major patients.
Kolnagou A; Michaelides Y; Kontoghiorghe CN; Kontoghiorghes GJ
Toxicol Mech Methods; 2013 Jan; 23(1):34-41. PubMed ID: 23039902
[TBL] [Abstract][Full Text] [Related]
2. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
[TBL] [Abstract][Full Text] [Related]
3. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
[TBL] [Abstract][Full Text] [Related]
4. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.
Christoforidis A; Haritandi A; Tsitouridis I; Tsatra I; Tsantali H; Karyda S; Dimitriadis AS; Athanassiou-Metaxa M
J Pediatr Hematol Oncol; 2006 May; 28(5):311-5. PubMed ID: 16772883
[TBL] [Abstract][Full Text] [Related]
5. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
6. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic iron and glucose dysregulation in thalassemia major.
Noetzli LJ; Mittelman SD; Watanabe RM; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):155-60. PubMed ID: 22120775
[TBL] [Abstract][Full Text] [Related]
8. Deferoxamine versus combined therapy for chelating liver, spleen and bone marrow iron in beta-thalassemic patients: a quantitative magnetic resonance imaging study.
Drakonaki EE; Maris TG; Maragaki S; Klironomos V; Papadakis A; Karantanas AH
Hemoglobin; 2010; 34(1):95-106. PubMed ID: 20113293
[TBL] [Abstract][Full Text] [Related]
9. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
[TBL] [Abstract][Full Text] [Related]
10. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major.
Au WY; Lam WW; Chu W; Tam S; Wong WK; Liang R; Ha SY
Haematologica; 2008 Jan; 93(1):116-9. PubMed ID: 18166794
[TBL] [Abstract][Full Text] [Related]
11. Iron metabolism in thalassemia intermedia.
Fiorelli G; Fargion S; Piperno A; Battafarano N; Cappellini MD
Haematologica; 1990; 75 Suppl 5():89-95. PubMed ID: 2086386
[TBL] [Abstract][Full Text] [Related]
12. Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.
Musallam KM; Cappellini MD; Wood JC; Motta I; Graziadei G; Tamim H; Taher AT
Haematologica; 2011 Nov; 96(11):1605-12. PubMed ID: 21791471
[TBL] [Abstract][Full Text] [Related]
13. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major.
Papakonstantinou O; Alexopoulou E; Economopoulos N; Benekos O; Kattamis A; Kostaridou S; Ladis V; Efstathopoulos E; Gouliamos A; Kelekis NL
J Magn Reson Imaging; 2009 Apr; 29(4):853-9. PubMed ID: 19306409
[TBL] [Abstract][Full Text] [Related]
14. Severe iron overload in Blackfan-Diamond anemia: a case-control study.
Roggero S; Quarello P; Vinciguerra T; Longo F; Piga A; Ramenghi U
Am J Hematol; 2009 Nov; 84(11):729-32. PubMed ID: 19810012
[TBL] [Abstract][Full Text] [Related]
15. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients.
Rose C; Vandevenne P; Bourgeois E; Cambier N; Ernst O
Eur J Haematol; 2006 Aug; 77(2):145-9. PubMed ID: 16608501
[TBL] [Abstract][Full Text] [Related]
16. T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients.
Hashemieh M; Azarkeivan A; Akhlaghpoor S; Shirkavand A; Sheibani K
Arch Iran Med; 2012 Feb; 15(2):91-4. PubMed ID: 22292579
[TBL] [Abstract][Full Text] [Related]
17. Assessmrent of iron overload in thalassaemic patients by magnetic resonance imaging: a pilot study.
Kumar P; Jagannathan NR; Choudhry VP
J Indian Med Assoc; 2007 Oct; 105(10):561-4, 591. PubMed ID: 18383951
[TBL] [Abstract][Full Text] [Related]
18. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major.
Mavrogeni SI; Markussis V; Kaklamanis L; Tsiapras D; Paraskevaidis I; Karavolias G; Karagiorga M; Douskou M; Cokkinos DV; Kremastinos DT
Eur J Haematol; 2005 Sep; 75(3):241-7. PubMed ID: 16104881
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of heart and liver iron deposition status in patients with β- thalassemia intermedia and major with MRI T2* technique].
Li CG; Liu SX; Mai HR; Wang Y; Wen FQ; Liu RY; Zhang XH; Chu WC; Au WY
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Feb; 14(2):110-3. PubMed ID: 22357467
[TBL] [Abstract][Full Text] [Related]
20. Abdominal lymphadenopathy in beta-thalassemia: MRI features and correlation with liver iron overload and posttransfusion chronic hepatitis C.
Papakonstantinou O; Maris TG; Kostaridou S; Ladis V; Vasiliadou A; Gourtsoyiannis NC
AJR Am J Roentgenol; 2005 Jul; 185(1):219-24. PubMed ID: 15972427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
